Repigmentation Observed With Ruxolitinib Cream in Vitiligo Trials
Results from both studies demonstrated that ruxolitinib met the primary endpoint with a greater proportion of patients achieving F-VASI75 at week 24.
Vitiligo
Ruxolitinib Cream a Promising Option for Long-Term Vitiligo Treatment
The safety and efficacy of ruxolitinib cream following 104 weeks of treatment in a phase 2 study of adults is reported.
Do Patients With Vitiligo Have Higher Risk for Metabolic Disturbances?
The prevalence and association of metabolic syndrome in patients with vitiligo was determined via analyses in this study.
Vitiligo: Present and Future, With John E. Harris, MD
Expert on vitiligo John E. Harris, MD, associate professor of dermatology at University of Massachusetts Medical School (UMMS) in Worcester, spoke with us about the skin disorder.
Platelet-Rich Plasma Added to MPG/Phototherapy May Lead to Earlier Repigmentation Response
Treatment outcomes for the mini punch grafting/phototherapy treatment with and without PRP were assessed in patients with vitiligo.
Comparing Site Preparation Methods for the Surgical Treatment of Vitiligo
The efficacy of recipient site preparation using dermabrasion, cryoblister, and dermaroller followed by NCES in stable vitiligo were compared.
Trailblazing Black Dermatologists Paved Way for Research, Contemporaries
Lynn McKinley-Grant, MD, describes how precedents were set in the treatment of skin of color by greats John Kenney Jr., MD, and Susan Taylor, MD.
Combination Treatment Modalities May be Ideal for Pediatric Patients With Vitiligo
Recent studies regarding therapeutic strategies to treat children with vitiligo are reviewed.
Apremilast and Narrow-Band UVB Improves Repigmentation Rate in Patients With Vitiligo and Skin of Color
The efficacy of treatment with apremilast plus NB-UVB compared with NB_UVB alone in skin phototypes IV through VI with vitiligo were evaluated.
Increased Dementia Risk Seen in Patients With Vitiligo
Patients with vitiligo may be more likely to develop dementia than patients without vitiligo, according to a retrospective cohort study.
- Loading...
Loading...
Next post in General Dermatology
Loading... 
Loading...